Liu I-Min, Tzeng Thing-Fong, Liou Shorong-Shii, Chang Chia Ju
Department of Pharmacy & Graduate Institute of Pharmaceutical Technology, Tajen University, 20 Weishin Road, Yanpu Shiang, Yen-Pou, Ping Tung Shien, Taiwan, ROC.
J Ethnopharmacol. 2009 Jul 15;124(2):211-8. doi: 10.1016/j.jep.2009.04.021. Epub 2009 May 3.
Wu-Ling-San (Hoelen Five Herb Formula) is a Chinese prescription used to promote water metabolism.
The present study was undertaken to characterize the effects of Wu-Ling-San on diabetic nephropathy.
Streptozotocin (STZ)-diabetic rats were orally administrated with Wu-Ling-San (0.5, 1.5, 2.5 g/(kgday)) once a day for 10 weeks. Changes in the renal function related parameters in plasma and urine were analyzed at the end of 10-week administration. Kidney was isolated for pathology histology, immunohistochemistry staining and Western blot analyses.
Wu-Ling-San (2.5 g/(kgday)) partially decreased the high plasma glucose level in diabetic rats. Diabetic-dependent alterations in urinary albumin, 24-h urinary albumin excretion rate, creatinine clearance, and glomerular mesangial matrix expansion were ameliorated by Wu-Ling-San. The increased expression of nuclear factor-kB as well as transforming growth factor-beta(1) and the progressive accumulation of fibronectin in kidney of diabetic rats were attenuated by Wu-Ling-San. Not only the elevated levels of advanced glycation end products (AGEs) and mitochondrial thiobarbituric acid-reactive substance, but also the higher levels of N(epsilon)-(carboxymethyl)lysine and receptor for AGEs in kidney of diabetic rats were ameliorated by Wu-Ling-San.
: Wu-Ling-San possess an anti-diabetic property with plasma glucose lowering action accompanied with amelioration of glycation-mediated renal damage.
五苓散是一种用于促进水液代谢的中药方剂。
本研究旨在阐明五苓散对糖尿病肾病的作用。
将链脲佐菌素(STZ)诱导的糖尿病大鼠每天口服给予五苓散(0.5、1.5、2.5 g/(kg·天)),持续10周。给药10周结束时分析血浆和尿液中与肾功能相关的参数变化。分离肾脏进行病理组织学、免疫组织化学染色和蛋白质印迹分析。
五苓散(2.5 g/(kg·天))可部分降低糖尿病大鼠的高血糖水平。五苓散改善了糖尿病相关的尿白蛋白、24小时尿白蛋白排泄率、肌酐清除率及肾小球系膜基质扩张的改变。五苓散减弱了糖尿病大鼠肾脏中核因子-κB以及转化生长因子-β1表达的增加和纤连蛋白的逐渐积累。五苓散不仅改善了糖尿病大鼠肾脏中晚期糖基化终产物(AGEs)和线粒体硫代巴比妥酸反应性物质水平的升高,还改善了Nε-(羧甲基)赖氨酸和AGEs受体的较高水平。
五苓散具有降血糖作用的抗糖尿病特性,并伴有改善糖基化介导的肾脏损伤。